transfection technology market
DUBLIN, March 22, 2024 (GLOBE NEWSWIRE) — Products (kits, equipment), methods (physics (electroporation, microinjection), biochemistry (lipofection, calcium phosphate), viruses), applications (biomedical research 'Global Transfection Technology Market' by (Separate), Therapeutic Delivery – Forecast to 2028'' report has been added. ResearchAndMarkets.com Recruitment.
The global transfection technology market is expected to reach a significant milestone, expanding to a valuation of USD 1.8 billion by 2028, at a compound annual growth rate (CAGR) of 9.4%.
This significant growth forecast, estimated at US$1.2 billion in 2023, is driven by technological enhancements in physical transfection methods, increased cell biology research and development, the proliferation of personalized medicine, and increased demand for cutting-edge therapeutic products. is supported by
Among various products, kits and reagents emerged as the key segment of the transfection technology industry in 2022. Growth in this sector is driven by the increasing demand for high-quality reagents essential for efficient transfection of nucleic acids into cells. Furthermore, these technologies are gaining momentum as they play a key role in the development of personalized medicine approaches and highly effective treatments.
The North America region demonstrated its dominance in the field of transfection technology in 2022 and is expected to maintain its dominance throughout the forecast period 2023-2028. The region's leading position can be attributed to its strong network of academic research institutions involved in vital drug discovery initiatives. Additionally, with increased investment in biologics and advanced dosage forms, along with efforts to expedite drug development timelines, North America represents a thriving ecosystem that is driving the growth of transfection technologies.
Numerous insights from the primary interviews conducted provide a comprehensive understanding of market dynamics, including a breakdown of 70% supply-side and 30% demand-side perspectives. Notably, the report includes a complex analysis of competitive strategies, collaborative efforts, and recent initiatives within the industry, painting a holistic picture of the market direction.
Research highlights and strategic insights
-
Analysis of crucial market drivers such as rising investments in cell and gene therapy, increasing research and development activities, and breakthrough technological advancements.
-
We provide a detailed assessment of market constraints, including the limitations of transfection methods and the rapid adoption of alternative techniques.
-
Exclusive coverage of new opportunities emerging in personalized medicine and untapped potential in developing economies.
-
Understand the market challenges in detail, highlighting cytotoxicity concerns and difficulties in large-scale transfection.
The comprehensive content extends to product innovation and signals major advances and new product offerings in the field of transfection technology. The report opens a window into current market developments, lucrative markets, diversification avenues and provides a fine-grained competitive assessment of the top industry players.
Introduced companies
-
Thermo Fisher Scientific Co., Ltd.
-
Bio-Rad Laboratories, Inc.
-
Qiagen
-
Merck KGaA
-
Sartorius AG (Polyplus)
-
Lonza
-
F. Hoffman La Roche Co., Ltd.
-
Agilent Technologies Co., Ltd.
-
max site
-
Liberty
-
Takara Bio Co., Ltd.
-
Promega Co., Ltd.
-
Danaher Corporation
-
Bock Sciences
-
Rjh Bioscience
-
symbolax
-
Altogen Biosystems
-
bioibbuto
-
Incera GmbH
-
invivogen
-
Foreus Biotech
-
stem cell technologies
-
Ez Biosystems
-
oz bioscience
-
chemicell company
For more information about this report, please visit https://www.researchandmarkets.com/r/svrl4k.
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source of international market research reports and market data. We provide the latest data on international and regional markets, key industries, top companies, new products and latest trends.
attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
